Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Rage Bio works in Biotechnology Research, out of Melbourne. It is privately held, and its site is ragebio.com. It holds one address on record, all in Australia. Headcount on record is 8. The latest round on record is Seed at US$3.7M. The record links five similar brands, most of them in Biotechnology Research.
Rage Bio is a pharmaceutical company a company developing precision splice-switching oligonucleotide (SSO) therapeutics to fight chronic inflammatory disease.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
| Rounds | 1 |
|---|---|
| Axis | 2020 to 2026 |
| Seed · 9 Dec 2021 | US$ 3.7M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
8 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: Melbourne.
One round. Latest 9 December 2021: Seed, US$3,700,000, investor IP Group.
21 profiles list Rage Bio as a peer — 94th percentile in Biotechnology Research. It lists ten peers of its own. Cincera Therapeutics Pty Ltd and Jumar Bioincubator list it back.